Document is current
Any future updates will be listed below
-
Authors
Faner, Rosa https://orcid.org/0000-0002-8159-0115
Morrow, Jarrett D.
Casas-Recasens, Sandra
Cloonan, Suzanne M.
Noell, Guillaume
López-Giraldo, Alejandra
Tal-Singer, Ruth
Miller, Bruce E.
Silverman, Edwin K.
Agustí, Alvar
Hersh, Craig P.
-
Funding
Funding for this research was provided by:
Instituto de Salud Carlos III (PI15/00799, CP16/00039)
National Heart, Lung, and Blood Institute (P01 HL105339, R01 HL125583, R01 HL130512 and K99HL125899)
- License Information
-
More Information
Article History
Received: 5 July 2018
Accepted: 16 December 2018
First Online: 8 January 2019
Ethics approval and consent to participate
: The Ethic Committees of the participating institutions approved each of these three studies, and all participants signed their informed consent. ECLIPSE (NCT00292552, SC0104960). This study was approved by the IRB of the Hospital Clinic de Barcelona, IRB#HCB/2014/1127.
: Not applicable.
: BEM is an employee and shareholder of GlaxoSmithKline, the sponsor of ECLIPSE. RT-S is an employee and shareholder of GlaxoSmithKline, the sponsor of ECLIPSE.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
